|
Volumn 2, Issue 4, 2012, Pages 267-274
|
Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CABERGOLINE;
CLOZAPINE;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
PERGOLIDE;
PRAMIPEXOLE;
QUETIAPINE;
ROPINIROLE;
ROTIGOTINE;
SEROTONIN UPTAKE INHIBITOR;
ABNORMAL BEHAVIOR;
APPETITE DISORDER;
ARTICLE;
BEHAVIOR THERAPY;
BINGE EATING DISORDER;
BRAIN DEPTH STIMULATION;
CHRONIC FATIGUE SYNDROME;
CLINICAL FEATURE;
CLINICAL PRACTICE;
COMPULSION;
CROSS-SECTIONAL STUDY;
DISEASE ASSOCIATION;
DOPAMINE BRAIN LEVEL;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG WITHDRAWAL;
DYSKINESIA;
ELECTROENCEPHALOGRAM;
FIBROMYALGIA;
FUNCTIONAL MAGNETIC RESONANCE IMAGING;
HIGH RISK PATIENT;
HUMAN;
IMPULSE CONTROL DISORDER;
INTERNET ADDICTION;
IRRITABILITY;
LOW DRUG DOSE;
MEDICAL ETHICS;
MONOTHERAPY;
MOOD;
OBSESSIVE COMPULSIVE DISORDER;
PARKINSON DISEASE;
PATHOLOGICAL GAMBLING;
PATHOPHYSIOLOGY;
PHYSICIAN;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROLACTINOMA;
RECEPTOR AFFINITY;
RESTLESS LEGS SYNDROME;
RISK FACTOR;
SEXUAL BEHAVIOR;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SUPPORT GROUP;
WITHDRAWAL SYNDROME;
|
EID: 84875848859
PISSN: 21630402
EISSN: 21630933
Source Type: Journal
DOI: 10.1212/CPJ.0b013e318278be9b Document Type: Article |
Times cited : (60)
|
References (11)
|